Clinical Trial

A Clinical Study on Co-transplantation of Autologous Limbal Stem Cells and Corneal Stromal Stem Cells to Repair Corneal Injury

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This study aims to: 1) verify the feasibility of treating limbal stem cell deficiency (LSCD) caused by chemical injury with autologous limbal stem cell transplantation combined with corneal stromal stem cell transplantation; 2) evaluate the corneal healing patterns following autologous stem cell transplantation; and 3) establish a clinical intervention protocol based on autologous corneal stem cell transplantation. Sixty cases of single-eye LSCD were included.
Trial Details
NCT Number NCT06700655
Lead Sponsor Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions Limbal Stem Cells Deficiency
Enrollment 60 participants
Start Date 2024-12-01
Primary Completion 2028-12-01 (estimated)
Study Completion 2029-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-22